979P Initial results from the phase II randomized trial comparing TACE with irinotecan and mitomycin C to doxorubicin in intermediate stage HCC (IRITACE trial).
Saved in:
| Title: | 979P Initial results from the phase II randomized trial comparing TACE with irinotecan and mitomycin C to doxorubicin in intermediate stage HCC (IRITACE trial). |
|---|---|
| Authors: | Waidmann, O.1 (AUTHOR), Gruber-Rouh, T.2 (AUTHOR), Koch, C.3 (AUTHOR), Götze, T.O.4 (AUTHOR), Schultheiss, M.5 (AUTHOR), Herrmann, E.6 (AUTHOR), Steup, C.3 (AUTHOR), Trojan, J.7 (AUTHOR), Vogl, T.J.J.8 (AUTHOR), Zeuzem, S.3 (AUTHOR), Finkelmeier, F.7 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS669-S669. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.1039 |
